Global deaths from cancer and heart disease have declined, but progress is uneven — in 60% of countries the pace remains slow, finds a new Lancet study.
A single capsule altering the gut microbiome via faecal microbiota transplantation (FMT) showed long-lasting metabolic improvements—potentially reducing diabetes and heart disease risk for years.